Alkem Medtech to acquire 55% stake in Occlutech for EUR 99.4 million

Alkem Medtech, a subsidiary of Alkem Laboratories, has executed a binding offer to acquire up to a 55% stake in Swiss medical devices company Occlutech Holding AG for EUR 99.4 million (about ₹1,074 crore). The acquisition marks Alkem's entry into advanced cardiovascular devices.

“The acquisition of Occlutech opens up significant opportunities for Alkem MedTech, and reinforces Alkem’s long-term vision of becoming a global player in the medical devices industry.”thehindubusinessline.com

• 1 source
• thehindubusinessline.comAlkem Medtech to pick up majority stake in Swiss medical devices company for ₹1,074 crore - The HinduBusinessLineOur BureauFeb 13, 2026

Summarized from public sources; check the original articles before acting on it.